ketotifen has been researched along with Ache in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Excerpt | Relevance | Reference |
---|---|---|
"Based on potential contributions of mast cells to neurofibroma-associated itching, pain, and tenderness, the mast cell blocker ketotifen fumarate (Zaditen, Sandoz Pharmaceuticals Corp, Hanover, NJ) has been proposed as a treatment for these symptoms." | 9.07 | A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. ( Riccardi, VM, 1993) |
"Based on potential contributions of mast cells to neurofibroma-associated itching, pain, and tenderness, the mast cell blocker ketotifen fumarate (Zaditen, Sandoz Pharmaceuticals Corp, Hanover, NJ) has been proposed as a treatment for these symptoms." | 5.07 | A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. ( Riccardi, VM, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riccardi, VM | 1 |
1 trial available for ketotifen and Ache
Article | Year |
---|---|
A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching.
Topics: Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Ketotifen; Male; Neurofibroma; Pain; | 1993 |